Esperion Therapeutics (ESPR) Stock Forecast, Price Target & Predictions
ESPR Stock Forecast
Esperion Therapeutics stock forecast is as follows: an average price target of $16.00 (represents a 563.90% upside from ESPR’s last price of $2.41) and a rating consensus of 'Buy', based on 8 wall street analysts offering a 1-year stock forecast.
ESPR Price Target
ESPR Analyst Ratings
Buy
Esperion Therapeutics Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
May 04, 2022 | Serge Belanger | Needham | $12.00 | $6.53 | 83.77% | 397.93% |
May 04, 2021 | Derek Archila | Wells Fargo | $20.00 | $25.59 | -21.84% | 729.88% |
10
Esperion Therapeutics Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | - |
Avg Price Target | - | - | - |
Last Closing Price | $2.41 | $2.41 | $2.41 |
Upside/Downside | -100.00% | -100.00% | -100.00% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 03, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Jul 01, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Jun 20, 2024 | Bank of America Securities | Buy | Underperform | Downgrade |
May 22, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Jun 15, 2023 | Barclays | - | Overweight | Initialise |
Jun 15, 2023 | Guggenheim | - | Buy | Initialise |
Jun 15, 2023 | Cowen & Co. | - | Buy | Upgrade |
Jun 15, 2023 | Bank of America Securities | - | Buy | Upgrade |
Mar 16, 2023 | Needham | Buy | Buy | Hold |
Mar 07, 2023 | Credit Suisse | - | Neutral | Upgrade |
10
Esperion Therapeutics Financial Forecast
Esperion Therapeutics Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $33.97M | $25.79M | $24.33M | $18.82M | $18.98M | $18.84M | $18.84M | $15.40M | $14.41M | $40.66M | $7.98M | $9.64M | $3.83M | $212.24M | $1.84M | $982.00K | $981.00K |
Avg Forecast | $97.00M | $88.90M | $82.10M | $76.40M | $184.50M | $86.40M | $68.70M | $60.80M | $60.94M | $51.31M | $47.49M | $83.93M | $28.65M | $29.59M | $24.64M | $21.98M | $20.61M | $19.68M | $18.62M | $15.41M | $14.48M | $11.89M | $42.18M | $19.93M | $12.52M | $4.01M | $147.97M | $471.36K | $891.80K | $900.00K |
High Forecast | $114.61M | $105.04M | $97.00M | $90.27M | $217.99M | $102.09M | $81.17M | $66.88M | $77.05M | $52.24M | $47.49M | $83.93M | $32.62M | $29.59M | $29.12M | $25.97M | $24.35M | $19.68M | $18.62M | $15.41M | $14.48M | $11.89M | $42.18M | $19.93M | $12.52M | $4.01M | $147.97M | $471.36K | $891.80K | $900.00K |
Low Forecast | $86.90M | $79.64M | $73.55M | $68.44M | $165.29M | $77.40M | $61.55M | $55.42M | $52.11M | $50.38M | $47.49M | $83.93M | $22.09M | $29.59M | $22.08M | $19.69M | $18.46M | $19.68M | $18.62M | $15.41M | $14.48M | $11.89M | $42.18M | $19.93M | $12.52M | $4.01M | $147.97M | $471.36K | $891.80K | $900.00K |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.15% | 1.05% | 1.11% | 0.91% | 0.96% | 1.01% | 1.22% | 1.06% | 1.21% | 0.96% | 0.40% | 0.77% | 0.96% | 1.43% | 3.90% | 1.10% | 1.09% |
Forecast
Esperion Therapeutics EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-27.53M | $-37.06M | $-47.33M | $-41.16M | $-40.86M | $-52.06M | $-42.52M | $-51.54M | $-55.58M | $-32.37M | $-82.66M | $-95.39M | $-80.35M | $129.37M | $-73.97M | $-57.72M | $-64.29M |
Avg Forecast | $-80.06M | $-73.38M | $-67.76M | $-63.06M | $-152.28M | $-71.31M | $-56.70M | $-50.18M | $-50.29M | $-42.35M | $-39.20M | $-56.89M | $-23.64M | $-24.42M | $-20.34M | $-51.71M | $-69.18M | $-16.26M | $-15.38M | $-47.01M | $-11.96M | $-9.83M | $-34.86M | $-50.51M | $-10.34M | $-3.31M | $-122.26M | $-84.09M | $-736.88K | $-743.65K |
High Forecast | $-71.72M | $-65.73M | $-60.71M | $-56.49M | $-136.42M | $-63.89M | $-50.80M | $-45.74M | $-43.01M | $-41.58M | $-39.20M | $-45.51M | $-18.24M | $-24.42M | $-18.22M | $-41.37M | $-55.34M | $-16.26M | $-15.38M | $-37.61M | $-11.96M | $-9.83M | $-34.86M | $-40.41M | $-10.34M | $-3.31M | $-122.26M | $-67.27M | $-736.88K | $-743.65K |
Low Forecast | $-94.60M | $-86.70M | $-80.06M | $-74.51M | $-179.93M | $-84.26M | $-67.00M | $-55.20M | $-63.59M | $-43.12M | $-39.20M | $-68.26M | $-26.92M | $-24.42M | $-24.03M | $-62.06M | $-83.01M | $-16.26M | $-15.38M | $-56.42M | $-11.96M | $-9.83M | $-34.86M | $-60.62M | $-10.34M | $-3.31M | $-122.26M | $-100.91M | $-736.88K | $-743.65K |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.13% | 1.82% | 0.92% | 0.59% | 2.51% | 3.38% | 0.90% | 4.31% | 5.66% | 0.93% | 1.64% | 9.22% | 24.27% | -1.06% | 0.88% | 78.33% | 86.45% |
Forecast
Esperion Therapeutics Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-41.25M | $-49.94M | $-89.22M | $-68.46M | $-68.61M | $-80.27M | $-70.47M | $-78.55M | $-69.39M | $-43.67M | $-90.94M | $-104.48M | $-85.44M | $124.61M | $-78.25M | $-61.95M | $-68.38M |
Avg Forecast | $17.54M | $9.75M | $5.85M | $-23.39M | $91.62M | $-1.95M | $-17.54M | $-23.39M | $-27.34M | $-34.17M | $-33.56M | $-75.90M | $-93.90M | $-83.44M | $-119.18M | $-69.00M | $-87.41M | $-174.65M | $-175.37M | $-62.73M | $-428.43M | $-529.53M | $-348.03M | $-55.57M | $-709.87M | $-665.03M | $310.68M | $-88.95M | $-498.23M | $-368.13M |
High Forecast | $21.68M | $12.05M | $7.23M | $-20.22M | $113.24M | $-1.69M | $-15.17M | $-21.59M | $-19.88M | $-29.54M | $-29.01M | $-60.72M | $-70.87M | $-72.15M | $-103.05M | $-55.20M | $-69.93M | $-174.65M | $-175.37M | $-50.19M | $-428.43M | $-529.53M | $-348.03M | $-44.46M | $-709.87M | $-665.03M | $310.68M | $-71.16M | $-498.23M | $-368.13M |
Low Forecast | $15.17M | $8.43M | $5.06M | $-28.91M | $79.21M | $-2.41M | $-21.68M | $-28.79M | $-42.25M | $-42.23M | $-41.48M | $-91.09M | $-109.84M | $-103.13M | $-147.31M | $-82.81M | $-104.89M | $-174.65M | $-175.37M | $-75.28M | $-428.43M | $-529.53M | $-348.03M | $-66.69M | $-709.87M | $-665.03M | $310.68M | $-106.74M | $-498.23M | $-368.13M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.49% | 0.42% | 1.29% | 0.78% | 0.39% | 0.46% | 1.12% | 0.18% | 0.13% | 0.13% | 1.64% | 0.15% | 0.13% | 0.40% | 0.88% | 0.12% | 0.19% |
Forecast
Esperion Therapeutics SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $33.24M | $33.96M | $29.90M | $24.14M | $24.95M | $29.61M | $30.38M | $38.34M | $39.27M | $46.32M | $61.06M | $61.55M | $48.83M | $47.68M | $41.55M | $21.71M | $18.47M |
Avg Forecast | $123.18M | $112.90M | $104.26M | $97.02M | $234.30M | $109.72M | $87.24M | $77.21M | $77.38M | $65.16M | $60.31M | $40.65M | $36.38M | $37.57M | $31.30M | $27.91M | $26.17M | $24.99M | $23.64M | $19.56M | $18.38M | $15.10M | $53.56M | $25.31M | $15.90M | $5.09M | $187.87M | $598.46K | $1.13M | $1.14M |
High Forecast | $145.54M | $133.39M | $123.19M | $114.64M | $276.83M | $129.64M | $103.08M | $84.93M | $97.84M | $66.34M | $60.31M | $48.78M | $41.42M | $37.57M | $36.98M | $32.98M | $30.92M | $24.99M | $23.64M | $19.56M | $18.38M | $15.10M | $53.56M | $25.31M | $15.90M | $5.09M | $187.87M | $598.46K | $1.13M | $1.14M |
Low Forecast | $110.35M | $101.14M | $93.40M | $86.92M | $209.90M | $98.29M | $78.16M | $70.38M | $66.18M | $63.98M | $60.31M | $32.52M | $28.06M | $37.57M | $28.04M | $25.01M | $23.45M | $24.99M | $23.64M | $19.56M | $18.38M | $15.10M | $53.56M | $25.31M | $15.90M | $5.09M | $187.87M | $598.46K | $1.13M | $1.14M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.88% | 1.09% | 1.07% | 0.92% | 1.00% | 1.25% | 1.55% | 2.09% | 2.60% | 0.86% | 2.41% | 3.87% | 9.60% | 0.25% | 69.43% | 19.18% | 16.16% |
Forecast
Esperion Therapeutics EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 4 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.37 | $-0.00 | $-1.14 | $-0.93 | $-1.01 | $-1.27 | $-1.16 | $-2.13 | $-2.62 | $-1.67 | $-3.50 | $-3.89 | $-3.07 | $4.50 | $-2.84 | $-2.26 | $-2.52 |
Avg Forecast | $0.09 | $0.05 | $0.03 | $-0.12 | $0.47 | $-0.01 | $-0.09 | $-0.12 | $-0.14 | $-0.18 | $-0.17 | $0.05 | $-0.48 | $-0.43 | $-0.61 | $-0.65 | $-0.85 | $-0.93 | $-0.93 | $-1.04 | $-2.27 | $-2.80 | $-1.84 | $-2.52 | $-3.76 | $-3.52 | $1.65 | $-3.30 | $-2.64 | $-1.95 |
High Forecast | $0.11 | $0.06 | $0.04 | $-0.10 | $0.58 | $-0.01 | $-0.08 | $-0.11 | $-0.10 | $-0.15 | $-0.15 | $0.05 | $-0.36 | $-0.37 | $-0.53 | $-0.56 | $-0.73 | $-0.93 | $-0.93 | $-1.04 | $-2.27 | $-2.80 | $-1.84 | $-2.52 | $-3.76 | $-3.52 | $1.65 | $-3.30 | $-2.64 | $-1.95 |
Low Forecast | $0.08 | $0.04 | $0.03 | $-0.15 | $0.41 | $-0.01 | $-0.11 | $-0.15 | $-0.22 | $-0.22 | $-0.21 | $0.05 | $-0.56 | $-0.53 | $-0.76 | $-0.81 | $-1.05 | $-0.93 | $-0.93 | $-1.04 | $-2.27 | $-2.80 | $-1.84 | $-2.52 | $-3.76 | $-3.52 | $1.65 | $-3.30 | $-2.64 | $-1.95 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.86% | 0.00% | 1.75% | 1.10% | 1.09% | 1.37% | 1.12% | 0.94% | 0.93% | 0.91% | 1.39% | 1.03% | 0.87% | 2.73% | 0.86% | 0.86% | 1.29% |
Forecast
Esperion Therapeutics Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
ESPR | Esperion Therapeutics | $2.41 | $16.00 | 563.90% | Buy |
RMTI | Rockwell Medical | $2.33 | $9.00 | 286.27% | Buy |
KMDA | Kamada | $5.82 | $20.00 | 243.64% | - |
IRWD | Ironwood Pharmaceuticals | $3.52 | $11.67 | 231.53% | Buy |
PCRX | Pacira BioSciences | $17.03 | $35.00 | 105.52% | Hold |
ELAN | Elanco Animal Health | $13.44 | $26.50 | 97.17% | Buy |
AVDL | Avadel Pharmaceuticals | $10.75 | $17.80 | 65.58% | Buy |
ANIP | ANI Pharmaceuticals | $55.10 | $79.00 | 43.38% | Buy |
COLL | Collegium Pharmaceutical | $30.00 | $40.50 | 35.00% | Buy |
ALKS | Alkermes | $27.91 | $36.38 | 30.35% | Hold |
CTLT | Catalent | $59.00 | $74.25 | 25.85% | Hold |
NBIX | Neurocrine Biosciences | $123.29 | $147.35 | 19.51% | Buy |
ITCI | Intra-Cellular Therapies | $85.64 | $94.50 | 10.35% | Buy |
PBH | Prestige Consumer Healthcare | $82.67 | $89.50 | 8.26% | Buy |
DCPH | Deciphera Pharmaceuticals | $25.59 | $26.32 | 2.85% | Hold |
LFCR | Lifecore Biomedical | $7.48 | $6.50 | -13.10% | Buy |
PAHC | Phibro Animal Health | $23.39 | $18.67 | -20.18% | Buy |
AGRX | Agile Therapeutics | $1.51 | $1.00 | -33.77% | Buy |